Biotech Acquisition
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch BIOT and buy or sell other stocks, ETFs, and their options commission-free!About BIOT
Biotech Acquisition Co. is a blank check company, which engages in the effectuation of a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one business. The company was founded on September 3, 2020 and is headquartered in New York, NY.
CEOMichael Shleifer, PhD
CEOMichael Shleifer, PhD
Employees—
Employees—
HeadquartersNew York, New York
HeadquartersNew York, New York
Founded2020
Founded2020
Employees—
Employees—
BIOT Key Statistics
Market cap291.81M
Market cap291.81M
Price-Earnings ratio36.30
Price-Earnings ratio36.30
Dividend yield—
Dividend yield—
Average volume25.77K
Average volume25.77K
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$10.41
52 Week high$10.41
52 Week low$8.30
52 Week low$8.30
Stock Snapshot
With a market cap of 291.81M, Biotech Acquisition(BIOT) trades at $10.15. The stock has a price-to-earnings ratio of 36.30.
On 2025-12-18, Biotech Acquisition(BIOT) stock opened at —, reached a high of —, and a low of —.
The Biotech Acquisition(BIOT)'s current trading volume is 0, compared to an average daily volume of 25.77K.
In the last year, Biotech Acquisition(BIOT) shares hit a 52-week high of $10.41 and a 52-week low of $8.30.
In the last year, Biotech Acquisition(BIOT) shares hit a 52-week high of $10.41 and a 52-week low of $8.30.
People also own
Based on the portfolios of people who own BIOT. This list is generated using Robinhood data, and it’s not a recommendation.